Latest period
$1.08B
YoY change
+32.0%
5Y CAGR
+14.3%
Peak year (2025)
$1.05B
Latest annual
$1.05B
Free Cash Flow history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $1.05B
Free Cash Flow growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +32.0%
Free Cash Flow history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $1.05B | +32.0% | +$255.31M | ||
| 2024 | $798.08M | +3.3% | +$25.20M | ||
| 2023 | $772.88M | +96.1% | +$378.73M | ||
| 2022 | $394.15M | -38.0% | −$241.85M | ||
| 2021 | $636.00M | +17.7% | +$95.56M | ||
| 2020 | $540.44M | +77.8% | +$236.50M | ||
| 2019 | $303.93M | +9.7% | +$26.79M | ||
| 2018 | $277.15M | -6.5% | −$19.42M | ||
| 2017 | $296.57M | +9.9% | +$26.79M | ||
| 2016 | $269.78M | +102.2% | +$136.34M | ||
| 2015 | $133.44M | -23.8% | −$41.70M | ||
| 2014 | $175.15M | +4.7% | +$7.79M | ||
| 2013 | $167.36M | +3.8% | +$6.13M | ||
| 2012 | $161.23M | +33.8% | +$40.75M | ||
| 2011 | $120.48M | -13.7% | −$19.05M | ||
| 2010 | $139.53M | +20.4% | +$23.66M | ||
| 2009 | $115.88M | +117.1% | +$62.50M | ||
| 2008 | $53.37M | -22.5% | −$15.51M | ||
| 2007 | $68.88M | +79.0% | +$30.41M | ||
| 2006 | $38.47M | -58.3% | −$53.88M | ||
| 2005 | $92.35M | +45.0% | +$28.68M | ||
| 2004 | $63.67M | -36.5% | −$36.59M | ||
| 2003 | $100.26M | +13.7% | +$12.09M | ||
| 2002 | $88.17M | +204.2% | +$59.18M | ||
| 2001 | $28.98M | +127.9% | +$16.26M | ||
| 2000 | $12.72M | -68.4% | −$27.48M | ||
| 1999 | $40.20M | -2110.0% | +$42.20M | ||
| 1998 | −$2.00M | -90.9% | +$20.00M | ||
| 1997 | −$22.00M | +478.9% | −$18.20M | ||
| 1996 | −$3.80M | -58.2% | +$5.30M | ||
| 1995 | −$9.10M | -187.5% | −$19.50M | ||
| 1994 | $10.40M | +96.2% | +$5.10M | ||
| 1993 | $5.30M | -320.8% | +$7.70M | ||
| 1992 | −$2.40M | -57.1% | +$3.20M | ||
| 1991 | −$5.60M | — | — |
- 2025$1.05B+32.0%
- 2024$798.08M+3.3%
- 2023$772.88M+96.1%
- 2022$394.15M-38.0%
- 2021$636.00M+17.7%
- 2020$540.44M+77.8%
- 2019$303.93M+9.7%
- 2018$277.15M-6.5%
- 2017$296.57M+9.9%
- 2016$269.78M+102.2%
- 2015$133.44M-23.8%
- 2014$175.15M+4.7%
- 2013$167.36M+3.8%
- 2012$161.23M+33.8%
- 2011$120.48M-13.7%
- 2010$139.53M+20.4%
- 2009$115.88M+117.1%
- 2008$53.37M-22.5%
- 2007$68.88M+79.0%
- 2006$38.47M-58.3%
- 2005$92.35M+45.0%
- 2004$63.67M-36.5%
- 2003$100.26M+13.7%
- 2002$88.17M+204.2%
- 2001$28.98M+127.9%
- 2000$12.72M-68.4%
- 1999$40.20M-2110.0%
- 1998−$2.00M-90.9%
- 1997−$22.00M+478.9%
- 1996−$3.80M-58.2%
- 1995−$9.10M-187.5%
- 1994$10.40M+96.2%
- 1993$5.30M-320.8%
- 1992−$2.40M-57.1%
- 1991−$5.60M—
Free Cash Flow values are taken from IDEXX Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at IDEXX Laboratories (IDXX)
Free Cash Flow for IDEXX Laboratories (IDXX): headline value $1.08B · YoY +32.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, IDEXX Laboratories (IDXX) free cash flow totalled $1.05B – surged 32.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories free cash flow compounded at +14.3% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak free cash flow at $1.05B, with the historical low of −$22.00M recorded in 1997.
IDEXX Laboratories Free Cash Flow by Year
IDEXX Laboratories Free Cash Flow 2025: $1.05B
2025's free cash flow for IDEXX Laboratories came in at $1.05B, surged 32.0% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Free Cash Flow 2024: $798.08M
IDEXX Laboratories posted free cash flow of $798.08M in 2024, edged up 3.3% from 2023.
IDEXX Laboratories Free Cash Flow 2023: $772.88M
In 2023, IDEXX Laboratories reported free cash flow of $772.88M, surged 96.1% from 2022.
IDEXX Laboratories Free Cash Flow 2022: $394.15M
IDEXX Laboratories free cash flow in 2022 was $394.15M, plunged 38.0% below 2021.
IDEXX Laboratories Free Cash Flow 2021: $636.00M
IDEXX Laboratories free cash flow in 2021 was $636.00M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Free Cash Flow
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation